13F filing recap · Q4 2014

What did ValueAct Capital buy in Q4 2014?

Reported stock-position changes between this filing and the previous one.

Stock value

$15.96B

Positions

Estimated turnover

27.9%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

BKRBaker Hughes Co$840.91Mreported value+15.00M shares HALHalliburton Company$821.80Mreported value+20.89M shares

Increased positions

MSFTMicrosoft Corporation$3.45Breported value+774 shares+0.0%VRXValeant Pharmaceuticals International, Inc.$2.77Breported value+460.0K shares+2.4%FOXATwenty-First Century Fox, Inc.$1.12Breported value+5.10M shares+20.2%AGUAgrium Inc$776.22Mreported value+2.98M shares

Reduced positions

MSIMotorola, Inc.$1.18Breported value-11.32M shares-39.2%ADBEAdobe Inc.$1.16Breported value-7.85M shares-32.9%CBRECbre Group, Inc.$1.07Breported value-843.6K shares-2.6%COLRockwell Collins Inc.$377.20Mreported value-6.59M shares

Exited positions

FOXATwenty-First Century Fox, Inc.$157.73Mprior reported value-4.60M shares-100.0%